amifostine anhydrous has been researched along with Nasopharyngeal Neoplasms in 6 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral candidiasis is suggested as an objective, early, though indirect, endpoint for amifostine's radioprotective effect on salivary glands." | 2.71 | Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection. ( Dardoufas, K; Kolitsi, G; Kouloulias, V; Kyprianou, K; Nicolatou-Galitis, O; Papanikolaou, I; Pissakas, G; Sotiropoulou-Lontou, A; Velegraki, A; Yiotakis, I, 2003) |
| "Dermatomyositis is associated with malignancy in approximately 20-25% of cases." | 2.41 | Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. ( Clarke, SJ; Clifford, A; Izard, M; Vardy, J; Wong, E, 2002) |
| "A mouse model of pulmonary fibrosis was established using BLM." | 1.91 | Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway. ( Cheng, Y; Du, J; Huang, S; Pan, L; Wu, X; Yang, W; Zhang, M; Zhang, Y; Zhu, H, 2023) |
| "Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are two closely related entities that present with severe acute mucocutaneous reactions most often triggered by drugs." | 1.31 | Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report. ( Alpsoy, E; Demiral, AN; Simşir, V; Yerebakan, O, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, W | 1 |
| Pan, L | 1 |
| Cheng, Y | 1 |
| Wu, X | 1 |
| Huang, S | 1 |
| Du, J | 1 |
| Zhu, H | 1 |
| Zhang, M | 1 |
| Zhang, Y | 1 |
| Blanchard, P | 1 |
| Bourhis, J | 1 |
| Lacas, B | 1 |
| Le Teuff, G | 1 |
| Michiels, S | 1 |
| Pignon, JP | 1 |
| Demiral, AN | 1 |
| Yerebakan, O | 1 |
| Simşir, V | 1 |
| Alpsoy, E | 1 |
| Nicolatou-Galitis, O | 1 |
| Sotiropoulou-Lontou, A | 1 |
| Velegraki, A | 1 |
| Pissakas, G | 1 |
| Kolitsi, G | 1 |
| Kyprianou, K | 1 |
| Kouloulias, V | 1 |
| Papanikolaou, I | 1 |
| Yiotakis, I | 1 |
| Dardoufas, K | 1 |
| Kutter, J | 1 |
| Ozsahin, M | 1 |
| Monnier, P | 1 |
| Stupp, R | 1 |
| Vardy, J | 1 |
| Wong, E | 1 |
| Izard, M | 1 |
| Clifford, A | 1 |
| Clarke, SJ | 1 |
2 reviews available for amifostine anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Squamous Cell; Ch | 2015 |
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
Topics: Amifostine; Anaphylaxis; Combined Modality Therapy; Dermatomyositis; Humans; Magnetic Resonance Imag | 2002 |
1 trial available for amifostine anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection.
Topics: Amifostine; Candidiasis, Oral; Female; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Middle | 2003 |
3 other studies available for amifostine anhydrous and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway.
Topics: Amifostine; Animals; Bleomycin; Disease Models, Animal; Mammals; Mice; Nasopharyngeal Neoplasms; Pho | 2023 |
Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report.
Topics: Amifostine; Anti-Inflammatory Agents; Dose Fractionation, Radiation; Humans; Male; Methylprednisolon | 2002 |
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 2005 |